TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report / Colaci, Michele; Sebastiani, Marco; Sandri, Gilda; Meacci, M; Ferri, Clodoveo. - In: CASE REPORT IN INFECTIOUS DISEASES. - ISSN 2090-6633. - ELETTRONICO. - 2011:(2011), pp. 530568-530568.
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report.
COLACI, Michele;SEBASTIANI, Marco;SANDRI, Gilda;FERRI, Clodoveo
2011
Abstract
TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.
| File | Dimensione | Formato | |
|---|---|---|---|
|
530568.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
1.47 MB
Formato
Adobe PDF
|
1.47 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
